Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Unprotected left main revascularization in patients with acute coronary syndromes.
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis.
Caine, Rebecca
Shared Decision Making in Neurocritical Care.
Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).
See All 29 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).
Van Zant G, Shultz L. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp Hematol. 1989 Feb; 17(2):81-7.
View in:
PubMed
subject areas
Aging
Animals
Colony-Forming Units Assay
Colony-Stimulating Factors
Erythroblasts
Erythropoietin
Female
Granulocytes
Hematopoietic Stem Cells
Immunologic Deficiency Syndromes
Lymphokines
Macrophages
Male
Mice
Mice, Inbred C57BL
Mice, Inbred CBA
Mice, Inbred DBA
Mice, Mutant Strains
Tissue Inhibitor of Metalloproteinases
authors with profiles
Leonard Donald Shultz PhD